Editorial: Strengths and Challenges of Allo-SCT in the Modern Era

Frontiers in Oncology

卷:12

Mohamad Mohty¹  Rizwan Romee²  Alessandro Isidori³  Domenico Russo⁴  Michele Malagola⁴  Raffaella Greco⁵  Jacopo Peccatori⁵  Fabio Ciceri⁵ 

[1] Department of Hematology and Cellular Therapy, “Saint Antoine Hospital” AP-HP, Paris, France;

[2] Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States;

[3] Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy;

[4] Unit of Blood Diseases and Stem Cell Transplantation, ASST-Spedali Civili di Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy;

[5] Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy;

关键词: allogeneic SCT;    relapse prevention;    immune reconstitution;    cytomegalovirus (CMV);    CART;   

DOI  :  10.3389/fonc.2022.850403

来源: DOAJ

【 授权许可】

Unknown